Fig. 19.1 Inauguration of TARGIT Academy at the Royal Free Hospital, London with the faculty from the UCL and University of Mannheim and participants 19.2.1 Theory Days and Hands-on Training…
Fig. 10.1 Examples of assessment using BCCT.core Although patient-reported outcome measures are increasingly used and quality of life is a key measure of clinical effectiveness, the measures used fall short…
Matched pair analysis (I) EBRT + boost (III) Mannheim TARGIT-A QoL trial (II) IORT EBRT IORT-EBRT IORT-boost EBRT-boost Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) General pain I…
Fig. 2.1 TARGIT impairs the proliferative activity of wound fluids from breast cancer patients. This figure shows the colony formation assay. In (a), MCF-7 breast cancer cells were included in…
EBRT IORT p (95 % CI) Total No. (%) 112 (47.1) 126 (52.9) 238 Non-responders 4 0 4 Age, years (mean) 65.74 (SD 6.17) 64.76 (SD 6.45) 0.23 (−0.64–2.60)…
Fig. 8.1 Mammogram (a) of a patient with breast cancer who had received breast-conserving therapy and IORT as a boost 5 years previously. A well-circumscribed and partially calcified mass of…
Fig. 1.1 Rapid attenuation of the radiation dose as the distance increases The mechanism of action of this approach is described in detail later in this textbook. In brief, a…
CHAPTER 5 MUSCULOSKELETAL SYSTEM WILLIAM E. ERKONEN AND CAROL A. BOLES Normal Development Normal Extremity Images Upper Extremity Lower Extremity Variations of Normal Congenital and Developmental Anomalies Trauma Fractures and Dislocations…
